I understand CXS doing early due diligence on CYT as CXS...

  1. 37 Posts.
    I understand CXS doing early due diligence on CYT as CXS exhibits greater conficence of upcoming successful IND approval in US for omacetaxine. Clearly CXS looking to access additional local well advanced oncology drug development programs and exhibiting confidence its own management to repeat what others have struggled to do themselves in this country. Will be watching closely.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.